diazoxide has been researched along with Metabolic Syndrome in 1 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Metabolic Syndrome: A cluster of symptoms that are risk factors for CARDIOVASCULAR DISEASES and TYPE 2 DIABETES MELLITUS. The major components of metabolic syndrome include ABDOMINAL OBESITY; atherogenic DYSLIPIDEMIA; HYPERTENSION; HYPERGLYCEMIA; INSULIN RESISTANCE; a proinflammatory state; and a prothrombotic (THROMBOSIS) state.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This diet induces a type 2 diabetes/metabolic syndrome phenotype with hypertension." | 1.48 | Characterization of vascular dysregulation in meriones shawi after high-calorie diet feeding. ( Cherkaoui-Tangi, K; Lyoussi, B; Morel, N; Wibo, M, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyoussi, B | 1 |
| Cherkaoui-Tangi, K | 1 |
| Morel, N | 1 |
| Wibo, M | 1 |
1 other study available for diazoxide and Metabolic Syndrome
| Article | Year |
|---|---|
Characterization of vascular dysregulation in meriones shawi after high-calorie diet feeding.
Topics: Animals; Aorta; Arginine; Carbachol; Diabetes Mellitus, Type 2; Diazoxide; Endothelium, Vascular; En | 2018 |